​​​​​​​An add-on Parkinson’s med already available in various countries throughout Europe will soon make its way to U.S. patients.

Johnson & Johnson’s new sponsorship of “Give a Spit for Cancer” features comedian Hannibal Buress in the ongoing drive to register potential bone marrow…

In 2016, many pharma marketers embraced disease awareness and charitable causes to drive better consumer engagement across social networks, according to a new…

The fast and furious two-day Round 2 match-ups carved the pharma ad field down to 16, with disease awareness emerging as a winning theme.

It looks like we might be in for another big patent brawl between Sanofi and Regeneron on one side and Amgen on the other.

Another legal salvo has been fired against top insulin makers, accusing them of colluding on prices with PBMs CVS, Express Scripts and UnitedHealth’s OptumRx.

Thanks to the FDA, competition for Valeant's lead drug may be on its way sooner than the embattled drugmaker would like.

How would a “competitive bidding process” for drugs work? We may soon find out, if President Trump gets his way with the Republican healthcare bill.

In what could be a direct rebuttal to President Donald Trump’s view on foreign trade, Eli Lilly CEO David Ricks called any promotion of deglobalization “…